Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gastrointestinal Neoplasms × Trastuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 208 Stomach Neoplasms 17 Neoplasm Metastasis 13 Breast Neoplasms, Male 13 Neoplasms 8 Esophageal Neoplasms 8 Brain Neoplasms 7 Inflammatory Breast Neoplasms 6 Colorectal Neoplasms 4 Adenocarcinoma Of Esophagus 4 Triple Negative Breast Neoplasms 3 Urologic Neoplasms 2 HER2-positive Breast Cancer 2 Gallbladder Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Ductal, Breast 2 Adenocarcinoma 2 Urinary Bladder Neoplasms 1 Solid Cancers 1 Rectal Neoplasms 1 Patient Preference 1 Patient Compliance 1 Osteitis Deformans 1 Neoplasm, Residual 1 Meningeal Neoplasms 1 Malignant Solid Neoplasm 1 Locally Advanced Breast Cancer 1 Lethal Congenital Contracture Syndrome 2 1 Hormone Receptor Positive Breast Cancer 1

Interventions

Leucovorin 4 Irinotecan 4 Fluorouracil 4 Oxaliplatin 3 Bevacizumab 3 cobimetinib 2 Standard of Care 2 Specimen Handling 2 Panitumumab 2 Magnetic Resonance Spectroscopy 2 Ketamine 2 Hydroxychloroquine 2 Cisplatin 2 Capecitabine 2 ulixertinib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 tivozanib 1 sodium thiosulfate 1 rucaparib 1 romiplostim 1 rilotumumab 1 regorafenib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 osimertinib 1 napabucasin 1 lanreotide 1 irinotecan sucrosofate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡